Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477031
2.
Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lancet Oncol
; 23(10): e450-e458, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174631
3.
INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Nucleic Acids Res
; 48(21): 11958-11981, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170255
4.
The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma.
Dermatology
; 237(2): 283-290, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799209
5.
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study.
Cytotherapy
; 19(4): 500-513, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215654
6.
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
Cytotherapy
; 18(9): 1187-96, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424146
7.
Broadening the repertoire of melanoma-associated T-cell epitopes.
Cancer Immunol Immunother
; 64(5): 609-20, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854582
8.
Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor.
Cytotherapy
; 16(8): 1117-20, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831841
9.
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Oncoimmunology
; 13(1): 2318053, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404966
10.
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.
Oncoimmunology
; 13(1): 2290900, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125722
11.
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells.
Cytotherapy
; 15(6): 740-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23643305
12.
Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation.
Front Immunol
; 14: 1327977, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268913
13.
Pre-existing TGF-ß-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948507
14.
Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
Front Immunol
; 14: 1180997, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37359554
15.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586765
16.
Restoring tumor immunogenicity with dendritic cell reprogramming.
Sci Immunol
; 8(85): eadd4817, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418548
17.
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.
J Transl Med
; 10: 169, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909342
18.
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy.
Mol Ther Oncolytics
; 24: 417-428, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141398
19.
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions.
Expert Opin Biol Ther
; 22(5): 627-641, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35414331
20.
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
J Immunother Cancer
; 10(10)2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316062